Catalyst Capital Advisors LLC bought a new stake in Teleflex Incorporated (NYSE:TFX) during the second quarter, Holdings Channel reports. The institutional investor bought 55,000 shares of the medical technology company’s stock, valued at approximately $11,427,000. Teleflex makes up approximately 0.5% of Catalyst Capital Advisors LLC’s investment portfolio, making the stock its 25th largest position.

A number of other hedge funds and other institutional investors also recently modified their holdings of the company. Rice Hall James & Associates LLC boosted its stake in Teleflex by 24.9% in the second quarter. Rice Hall James & Associates LLC now owns 107,681 shares of the medical technology company’s stock valued at $22,372,000 after buying an additional 21,461 shares during the last quarter. First Trust Advisors LP boosted its stake in Teleflex by 55.7% in the second quarter. First Trust Advisors LP now owns 74,551 shares of the medical technology company’s stock valued at $15,489,000 after buying an additional 26,666 shares during the last quarter. Arizona State Retirement System boosted its stake in Teleflex by 31.0% in the second quarter. Arizona State Retirement System now owns 24,501 shares of the medical technology company’s stock valued at $5,090,000 after buying an additional 5,801 shares during the last quarter. Blue Sky Asset Management LLC acquired a new stake in Teleflex during the second quarter valued at $723,000. Finally, Solaris Asset Management LLC boosted its stake in Teleflex by 1.0% in the second quarter. Solaris Asset Management LLC now owns 26,844 shares of the medical technology company’s stock valued at $5,577,000 after buying an additional 278 shares during the last quarter. Institutional investors and hedge funds own 93.02% of the company’s stock.

Teleflex Incorporated (TFX) opened at 205.34 on Friday. The stock has a market capitalization of $9.25 billion, a PE ratio of 39.27 and a beta of 1.05. The company’s 50 day moving average price is $209.41 and its 200-day moving average price is $196.91. Teleflex Incorporated has a one year low of $136.53 and a one year high of $217.97.

Teleflex (NYSE:TFX) last released its quarterly earnings data on Thursday, August 3rd. The medical technology company reported $2.04 earnings per share for the quarter, topping analysts’ consensus estimates of $1.91 by $0.13. The firm had revenue of $528.60 million during the quarter, compared to analyst estimates of $518.98 million. Teleflex had a return on equity of 16.12% and a net margin of 12.36%. The business’s quarterly revenue was up 11.6% compared to the same quarter last year. During the same quarter in the prior year, the company posted $1.89 earnings per share. Analysts expect that Teleflex Incorporated will post $8.28 earnings per share for the current year.

The company also recently announced a quarterly dividend, which will be paid on Friday, September 15th. Investors of record on Tuesday, August 15th will be given a $0.34 dividend. The ex-dividend date is Friday, August 11th. This represents a $1.36 dividend on an annualized basis and a dividend yield of 0.66%. Teleflex’s dividend payout ratio is currently 26.00%.

ILLEGAL ACTIVITY NOTICE: This news story was first posted by Daily Political and is the sole property of of Daily Political. If you are viewing this news story on another website, it was copied illegally and reposted in violation of US & international trademark and copyright law. The correct version of this news story can be accessed at https://www.dailypolitical.com/2017/08/12/catalyst-capital-advisors-llc-buys-shares-of-55000-teleflex-incorporated-nysetfx.html.

Several analysts have weighed in on the company. BidaskClub cut Teleflex from a “hold” rating to a “sell” rating in a report on Tuesday. Jefferies Group LLC reaffirmed a “buy” rating and issued a $230.00 price target on shares of Teleflex in a report on Thursday, August 3rd. Needham & Company LLC reaffirmed a “buy” rating on shares of Teleflex in a report on Friday, August 4th. Deutsche Bank AG reaffirmed a “buy” rating and issued a $238.00 price target (up previously from $220.00) on shares of Teleflex in a report on Wednesday. Finally, Zacks Investment Research cut Teleflex from a “buy” rating to a “hold” rating in a report on Thursday, June 22nd. One analyst has rated the stock with a sell rating, one has issued a hold rating and six have given a buy rating to the company’s stock. The company currently has an average rating of “Buy” and a consensus target price of $228.00.

In related news, Director Stephen K. M.D. Klasko sold 200 shares of the business’s stock in a transaction dated Tuesday, August 1st. The stock was sold at an average price of $208.41, for a total value of $41,682.00. Following the sale, the director now directly owns 8,080 shares in the company, valued at $1,683,952.80. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. Also, Director Gretchen R. Haggerty bought 1,000 shares of the firm’s stock in a transaction that occurred on Wednesday, June 21st. The stock was purchased at an average price of $203.82 per share, for a total transaction of $203,820.00. Following the completion of the transaction, the director now directly owns 1,760 shares of the company’s stock, valued at approximately $358,723.20. The disclosure for this purchase can be found here. Insiders sold 8,300 shares of company stock worth $1,643,975 over the last quarter. 2.39% of the stock is owned by company insiders.

About Teleflex

Teleflex Incorporated is a provider of medical technology products. The Company designs, develops, manufactures and supplies single-use medical devices used by hospitals and healthcare providers for diagnostic and therapeutic procedures in critical care and surgical applications. The Company operates through six segments: Vascular North America; Anesthesia North America; Surgical North America; Europe, the Middle East and Africa (EMEA); Asia, and Original Equipment Manufacturer (OEM).

Want to see what other hedge funds are holding TFX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Teleflex Incorporated (NYSE:TFX).

Institutional Ownership by Quarter for Teleflex (NYSE:TFX)

Receive News & Ratings for Teleflex Incorporated Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Teleflex Incorporated and related companies with MarketBeat.com's FREE daily email newsletter.